XTX Topco Ltd Buys 87,481 Shares of agilon health, inc. (NYSE:AGL)

XTX Topco Ltd lifted its stake in shares of agilon health, inc. (NYSE:AGL) by 271.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 119,747 shares of the company’s stock after acquiring an additional 87,481 shares during the period. XTX Topco Ltd’s holdings in agilon health were worth $471,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. AQR Capital Management LLC grew its position in agilon health by 3,338.5% in the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after purchasing an additional 1,316,990 shares in the last quarter. Susquehanna Fundamental Investments LLC grew its position in agilon health by 65.0% in the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock valued at $5,262,000 after purchasing an additional 316,856 shares in the last quarter. Citigroup Inc. grew its position in agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after purchasing an additional 1,941,993 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund bought a new position in agilon health in the second quarter valued at $1,849,000. Finally, Neo Ivy Capital Management bought a new position in agilon health in the second quarter valued at $1,006,000.

Analyst Ratings Changes

A number of research analysts have recently commented on AGL shares. Royal Bank of Canada reissued an “outperform” rating and issued a $3.00 price objective on shares of agilon health in a research report on Tuesday, November 19th. Barclays decreased their price objective on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research report on Monday, November 11th. William Blair downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. JMP Securities downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Finally, Evercore ISI decreased their price objective on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research report on Tuesday, October 8th. Three investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $4.38.

agilon health Price Performance

Shares of agilon health stock opened at $2.24 on Friday. agilon health, inc. has a twelve month low of $1.50 and a twelve month high of $13.76. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a 50-day simple moving average of $2.44 and a two-hundred day simple moving average of $4.38. The stock has a market capitalization of $922.92 million, a price-to-earnings ratio of -2.38 and a beta of 0.51.

agilon health (NYSE:AGL) last released its earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The firm had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. During the same period in the prior year, the business earned ($0.06) earnings per share. Analysts forecast that agilon health, inc. will post -0.52 EPS for the current year.

Insider Buying and Selling at agilon health

In related news, Director John William Wulf purchased 45,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 5th. The shares were bought at an average cost of $2.18 per share, with a total value of $98,100.00. Following the acquisition, the director now owns 206,133 shares of the company’s stock, valued at $449,369.94. This trade represents a 27.93 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Diana Mckenzie purchased 12,500 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The shares were bought at an average cost of $2.28 per share, for a total transaction of $28,500.00. Following the completion of the acquisition, the director now directly owns 51,319 shares in the company, valued at $117,007.32. The trade was a 32.20 % increase in their position. The disclosure for this purchase can be found here. Insiders have bought a total of 90,000 shares of company stock valued at $198,100 in the last ninety days. 3.20% of the stock is currently owned by company insiders.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.